FDA NDC Directory · JSON-LD · Markdown

olmesartan medoxomil-hydrochlorothiazide

NDC 42291-925 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerAvKARE
Marketing categoryNew Drug Application (innovator) · App NDA021532
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (12.5 mg/1)
OLMESARTAN MEDOXOMIL (40 mg/1)
Marketing started20230727
Package count1

External sources

Source: openFDA. Public-domain (CC0).